The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Pfizer Ventures led the immuno-oncology drug developer's latest round, which was spun out of Institut Paoli-Calmettes with the help of Satt Sud-Est and Inserm Transfert.

Pfizer Ventures led the immuno-oncology drug developer's latest round, which included existing backer Boehringer Ingelheim Venture Fund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Impulse Dynamics, the developer of an implant for heart failure treatment, has collected $80.3m from investors including Zoll Medical, Abiomed and Minth Group.

Vanderbilt University joined fellow LPs including Consumer Technology Association in an oversubscribed close for the diversity-focused Harlem Partners Venture Fund I.

Echo Health Ventures added $7.5m to a round that already included GV and Centene, helping the mental health care provider expand it to $67.5m.

Diabetes management system developer Diabeloop will use the funding from the Agir à dom and Air Liquide-backed round to accelerate growth.

Hui-Gene collected $14.2m from investors including WuXi AppTec and the Mayo Clinic-backed Huimei Healthcare Management to progress its gene therapy pipeline toward clinical testing and production.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.